Formoterol Fumarate and M-M-R II Vaccine

• Generic Name: formoterol
• Dosage Forms: n.a.
• Other Brand Names: Perforomist, Foradil Aerolizer, Foradil Aerolizer>

Formoterol: Used concomitantly with long-term asthma controller therapy (e.g., inhaled corticosteroids) for prevention of bronchospasm in patients with reversible obstructive airway disease (e.g., asthma).

Monotherapy with long-acting β2-adrenergic agonists (e.g., formoterol) increases the risk of asthma-related death and may increase the risk of asthma-related hospitalization in children and adolescents. Use of formoterol alone for treatment of asthma without concomitant use of long-term asthma controller therapy (e.g., inhaled corticosteroids) is contraindicated. (See Asthma-related Death and Serious Asthma-related Events under Cautions.)

Formoterol in fixed combination with budesonide or mometasone (formoterol/budesonide, formoterol/mometasone): Treatment of asthma only in patients not responding adequately to long-term asthma controller therapy (e.g., inhaled corticosteroids) or whose disease severity clearly warrants initiation of treatment with both an inhaled corticosteroid and a long-acting β2-adrenergic agonist.

Once asthma control achieved and maintained, assess patient at regular intervals and step down therapy (e.g., discontinue formoterol or formoterol/budesonide) if possible without loss of asthma control, and maintain patient on long-term asthma controller therapy (e.g., inhaled corticosteroids).

Do not use formoterol/budesonide in patients with asthma adequately controlled on low or medium dosage of inhaled corticosteroids.

Formoterol alone or in fixed combination with budesonide or mometasone not indicated for relief of acute bronchospasm; do not initiate in patients with rapidly deteriorating or potentially life-threatening episodes of asthma. (See Acute Exacerbations of Asthma or COPD under Cautions.)

Formoterol, formoterol/budesonide, or formoterol in fixed combination with glycopyrrolate (formoterol/glycopyrrolate): Long-term maintenance treatment of bronchospasm or airflow obstruction associated with COPD, including chronic bronchitis and emphysema.

Do not initiate formoterol alone or in fixed combination with budesonide or glycopyrrolate in patients with substantially worsening or acutely deteriorating COPD; do not use to treat acute symptoms. (See Acute Exacerbations of Asthma or COPD under Cautions.)

Use of long-acting β2 agonists (e.g., formoterol) with or without inhaled corticosteroids for acute exacerbations of COPD not evaluated. Use a short-acting inhaled β2-adrenergic agonist intermittently (as needed) for acute symptoms of COPD.

• Generic Name: measles virus vaccine / mumps virus vaccine / rubella virus vaccine
• Dosage Forms: injection, powder, lyophilized, for suspension
• Other Brand Names: M-M-R II

Measles, mumps, and rubella are serious diseases caused by viruses spread from person to person through the air. Measles, mumps, and rubella can cause minor symptoms such as fever, headache, sore throat, cough, swollen glands, runny nose, eye irritation, skin rash, muscle aches, and joint pain.

More serious symptoms of measles or mumps include pneumonia, hearing loss, painful swelling of the testicles or ovaries, and rarely permanent brain damage or death.

Becoming infected with rubella virus (also called German Measles) during pregnancy can result in a miscarriage or serious birth defects.

The measles, mumps, and rubella (MMR) vaccine is used to help prevent these diseases by causing your body to develop immunity to the disease. This vaccine will not treat an active infection that has already developed in the body.

MMR vaccine is for use in children between the ages of 12 months and 6 years old, and in adults who have never received the vaccine or had the diseases.

Like any vaccine, the MMR vaccine may not provide protection from disease in every person.